“A robotic truck equipped with a 105-ft (32-m) telescopic boom arm has just journeyed from Australia to Florida. Now the construction robot will get busy churning out up to 10 houses in a bid to become the employee of choice for building entire communities.

The truck and its accompanying brick-laying arm is known as the Hadrian X and has been developed by robotics company FBR, which first announced its prototype in 2015. That machine could complete a full-sized house in two days. Last year, FBR (which used to stand for Fastbrick Robotics), showed off the new Hadrian X which, at top speed, could stack 500 USA-format masonry blocks per hour.”

From New Atlas.

“In just the past couple of years, a number of startups have developed processes for creating all sorts of small objects from composites, in a way that is fast and inexpensive. These include Berkeley, Calif.-based Arris Composites, 9T Labs in Zurich, Orbital Composites in Silicon Valley, and others.

Shifting substantial portions of what we make and use from steel and plastic to composites—which are amalgamations of a variety of fibers, embedded in a variety of plastics—could bring new kinds of transportation, more terrifying weapons of war, and lighter and more durable smartphones, wearables and other consumer electronics.

All of that is possible because composites, while they have their challenges, are often able to perform just as well as high-strength metal parts, but with a fraction of the weight. Composites are the reason modern jetliners are so fuel-efficient, and the entire wind-power industry would be impossible without enormous turbine blades made from composites.”

From Wall Street Journal.

“The effectiveness of semaglutide, sold as the diabetes drug Ozempic and weight-loss drug Wegovy, contributed to its overwhelming popularity and huge demand. This led to global shortages throughout 2022–23, which maker Novo Nordisk says will likely continue into this year. The shortage has particularly affected type 2 diabetics who rely on semaglutide to keep their blood glucose levels under control and are left searching for suitable alternatives.

Researchers at The Florey Institute in Melbourne, Australia, may have discovered a way of addressing the critical shortage, developing a method of production of a drug analog that has the same therapeutic effects as semaglutide. Their novel production method is not only cost-effective and simpler but produces far more of the drug.”

From New Atlas.

“The Australian government has announced it will abolish close to 500 ‘nuisance’ tariffs from July 1, reducing the cost of importing everything from toothbrushes to roller coasters and bumper cars.

Described by the center-left Labor government as the biggest unilateral tariff reform in at least two decades, removing the tariffs will cost the budget $19.9 million (30 million Australian dollars) in lost revenue annually, but help to streamline $5.6 billion (A$8.5 billion) in annual trade.”

From Wall Street Journal.